secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2022-02-07T23:59:59+00:00
Accession:  0001193125-22-029787
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Coherus appoints Dr. Lee Newcomer to board; Dr. James Healy resigns
-------------------------------------------------------------------

- Appointed Dr. Lee Newcomer to Board effective Feb 2; receives option for 54k shares plus $50k annual retainer.
- Newcomer is former UnitedHealth CMO, brings oncology and payer expertise to board.
- Director James Healy resigned Feb 4; departure not due to any disagreement.
- Mark Stolper reclassified from Class III to Class II to equalize board class sizes.
- Board expanded to 7 members; now 2 directors per class.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000119312522029787/0001193125-22-029787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000119312522029787/d298250d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-029787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer